Egidi MF - Search Results

1

Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.

Patel SJ, Duhart BT Jr, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO. Patel SJ, et al. Among authors: egidi mf. Transplantation. 2008 Jul 27;86(2):313-20. doi: 10.1097/TP.0b013e31817ef190. Transplantation. 2008. PMID: 18645496

2

Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.

Lo A, Egidi MF, Gaber LW, Shokouh-Amiri MH, Nazakatgoo N, Fisher JS, Gaber AO. Lo A, et al. Among authors: egidi mf. Clin Transplant. 2004 Feb;18(1):53-61. doi: 10.1111/j.1399-0012.2004.00116.x. Clin Transplant. 2004. PMID: 15108771 Clinical Trial.

3

Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation.

Lo A, Egidi MF, Gaber LW, Amiri HS, Vera S, Nezakatgoo N, Gaber AO. Lo A, et al. Among authors: egidi mf. Transplantation. 2004 Apr 27;77(8):1228-35. doi: 10.1097/01.tp.0000121504.69676.5e. Transplantation. 2004. PMID: 15114090 Clinical Trial.

4

Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.

Trofe J, Stratta RJ, Egidi MF, Lo A, Gaber LW, Shokouh-Amiri MH, Grewal HP, Honaker M, Hardinger K, Alloway RR, Gaber AO. Trofe J, et al. Among authors: egidi mf. Clin Transplant. 2002;16 Suppl 7:34-44. doi: 10.1034/j.1399-0012.16.s7.5.x. Clin Transplant. 2002. PMID: 12372042

5

Clinical utility of histological features of polyomavirus allograft nephropathy.

Gaber LW, Egidi MF, Stratta RJ, Lo A, Moore LW, Gaber AO. Gaber LW, et al. Among authors: egidi mf. Transplantation. 2006 Jul 27;82(2):196-204. doi: 10.1097/01.tp.0000226176.87700.a4. Transplantation. 2006. PMID: 16858282

6

Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study.

Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kizilisik AT, Alloway RR, Gaber LW, Gaber AO. Lo A, et al. Among authors: egidi mf. Clin Transplant. 2000 Dec;14(6):572-9. doi: 10.1034/j.1399-0012.2000.140610.x. Clin Transplant. 2000. PMID: 11127311

7

Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients.

Lo A, Egidi MF, Gaber LW, Gaber AO. Lo A, et al. Among authors: egidi mf. Transplant Proc. 2003 May;35(3 Suppl):105S-108S. doi: 10.1016/s0041-1345(03)00238-0. Transplant Proc. 2003. PMID: 12742477 Clinical Trial.

8

Impact of hepatitis C virus status in pancreas transplantation: a case controlled study.

Honaker MR, Stratta RJ, Lo A, Egidi MF, Shokouh-Amiri MH, Grewal HP, Alloway RR, Gaber LW, Hardinger KL, Gaber AO. Honaker MR, et al. Among authors: egidi mf. Clin Transplant. 2002 Aug;16(4):243-51. doi: 10.1034/j.1399-0012.2002.01116.x. Clin Transplant. 2002. PMID: 12099979 Review.

9

Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation.

Al-Jedai AH, Honaker MR, Trofe J, Egidi MF, Gaber LW, Gaber AO, Stratta RJ. Al-Jedai AH, et al. Among authors: egidi mf. Transplantation. 2003 Feb 27;75(4):490-4. doi: 10.1097/01.TP.0000045684.75705.7A. Transplantation. 2003. PMID: 12605116

10

Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids.

Egidi MF, Gaber AO. Egidi MF, et al. Transplantation. 2003 Feb 27;75(4):572; author reply 573. doi: 10.1097/01.TP.0000046940.27269.43. Transplantation. 2003. PMID: 12605133 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters